Literature DB >> 16164042

The role of CD24 in various human epithelial neoplasias.

Sung-Chul Lim1, Seon-Hee Oh.   

Abstract

CD24 is a small, heavily glycosylated glycosylphosphatidylinositol-linked cell surface protein, which is expressed in hematologic malignancies and in a large variety of solid tumors. It appears to function as a ligand of P-selectin, an adhesion molecule present in activated platelets and endothelial cells. The authors aimed at evaluating CD24 protein expression in adenoma and adenocarcinoma of the stomach, colon, gallbladder, ovary, and breast to establish a correlation with clinicopathologic data. Staining was evaluated using four degrees of positivity (negative, weakly, moderately, strongly positive), and the staining patterns (membranous vs. intracytoplasmic) were analyzed for statistical analysis. The present study clearly demonstrates that CD24 is abundantly expressed in adenocarcinoma compared to adenoma of the colon and breast. Moreover, the positivity degree of CD24 expression increases with positive nodal status in advanced gastric carcinoma. Intracytoplasmic CD24 expression was found to be highly associated with adenocarcinoma of the colon, gallbladder, and ovary compared to the adenoma group of those organs, and with the positive nodal status compared to the negative nodal status of the colonic adenocarcinoma. We conclude that the degree of positivity and the staining pattern of CD24 constitute an important molecular marker for various epithelial neoplasms, which could help to define malignant transformation and to predict lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164042     DOI: 10.1016/j.prp.2005.05.004

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  32 in total

Review 1.  Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.

Authors:  Tony Blick; Honor Hugo; Edwin Widodo; Mark Waltham; Cletus Pinto; Sendurai A Mani; Robert A Weinberg; Richard M Neve; Marc E Lenburg; Erik W Thompson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-06-04       Impact factor: 2.673

2.  CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance.

Authors:  Sibel Bektas; Burak Bahadir; Bulent Hamdi Ucan; Sukru Oguz Ozdamar
Journal:  Pathol Oncol Res       Date:  2010-02-23       Impact factor: 3.201

3.  CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.

Authors:  Alexandra Winkler; Richard Zigeuner; Peter Rehak; Georg Hutterer; Thomas Chromecki; Cord Langner
Journal:  Virchows Arch       Date:  2006-11-17       Impact factor: 4.064

4.  Sox9 expression marks a subset of CD24-expressing small intestine epithelial stem cells that form organoids in vitro.

Authors:  Adam D Gracz; Sendhilnathan Ramalingam; Scott T Magness
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-02-25       Impact factor: 4.052

Review 5.  Stem cells in colon cancer. A new era in cancer theory begins.

Authors:  Joanna Papailiou; Konstaninos J Bramis; Maria Gazouli; George Theodoropoulos
Journal:  Int J Colorectal Dis       Date:  2010-08-03       Impact factor: 2.571

6.  Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma.

Authors:  J Tang; H Cai; L Lin; P Xie; W Zhong; M Tang
Journal:  Clin Transl Oncol       Date:  2012-11-10       Impact factor: 3.405

7.  CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy.

Authors:  Agnieszka Adamczyk; Joanna A Niemiec; Aleksandra Ambicka; Anna Mucha-Małecka; Jerzy Mituś; Janusz Ryś
Journal:  J Mol Histol       Date:  2013-07-09       Impact factor: 2.611

8.  NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma.

Authors:  Shi-peng Song; Sheng-bin Zhang; Rui Liu; Li Yao; Yu-qin Hao; Ming-mei Liao; Yang-de Zhang; Zhe-hai Li
Journal:  Med Oncol       Date:  2011-12-02       Impact factor: 3.064

Review 9.  Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays.

Authors:  Miriam Romaguera-Ros; María Peris-Celda; Jorge Oliver-De La Cruz; Josefa Carrión-Navarro; Arantxa Pérez-García; Jose Manuel García-Verdugo; Angel Ayuso-Sacido
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

10.  Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.

Authors:  Julio E Celis; Teresa Cabezón; José M A Moreira; Pavel Gromov; Irina Gromova; Vera Timmermans-Wielenga; Takuji Iwase; Futoshi Akiyama; Naoko Honma; Fritz Rank
Journal:  Mol Oncol       Date:  2009-02-03       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.